References
- Mercer BM, Goldenberg RL,, Meis PJ, Moawad AH, Shellhaas C, Das A, et al. The Preterm Prediction Study: Prediction of preterm premature rupture of membranes through clinical findings and ancillary testing. Am J Obstet Gynecol 2000;183:738–745.
- Capeless EL, Mead PB. Management of preterm premature rupture of membranes: Lack of a national consensus. Am J Obstet Gynecol 1987;157:11–12.
- Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Out-comes. JAMA 1995;273:413–418.
- National Institutes of Health Consensus Development Panel. Antenatal corticosteroids revisited: repeat courses - National Institutes of Health Consensus Development Conference Statement, 17-18 August 2000. Obstet Gynecol. 2001;98: 144–150.
- ACOG Practice Bulletin, No. 1. 'Premature Rupture of Membranes'. Washington, DC: American College of Obste-tricians and Gynecologists, June 1998.
- Ohlsson A. Treatment of preterm premature rupture of the membranes: A meta-analysis. Am J Obstet Gynecol 1989;160: 890–906.
- Garite TJ. Management of premature rupture of membranes. Clin Perinatol 2001;28:837–844.
- Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol 2003;101:178–193.
- Ramsey PS, Nuthalapaty FS, Lu G, Ramin S, Nuthalapaty ES, Ramin KD. Contemporary management of preterm premature rupture of membranes (PPROM): A survey of maternal-fetal medicine providers. Am J Obstet Gynecol 2004;191:1497–502.
- West SL, King V, Carey TS, et al. Systems to rate the strength of scientific evidence. Evidence Report, Technology Assess-ment No. 47. AHRQ Publication No. 02-E016. Rockville, MD: Agency for Healthcare Research and Quality, 2002.
- Garite TJ, Keegan KA, Freeman RK, Nageotte MP. A randomized trial of ritodrine tocolysis versus expectant management in patients with premature rupture of mem-branes at 25 to 30 weeks of gestation. Am J Obstet Gynecol 1987;157:388–393.
- Weiner CP, Renk K, Klugman M. The therapeutic efficacy and cost-effectiveness of aggressive tocolysis for premature labor associated with premature rupture of the membranes. Am J Obstet Gynecol 1988;159:216–222.
- Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Ramsey RD, et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. JAMA 1997;278:989–995.
- Fujikura T, Froehlich LA. The influence of race and other factors on pulmonary hyaline membranes: A report from the Collaborative Study of Cerebral Palsy. Am J Obstet Gynecol 1966;95:572–578.
- Hulsey TC, Alexander GR, Robillard PY, Annibale DJ, Keenan A. Hyaline membrane disease: The role of ethnicity and maternal risk characteristics. Am J Obstet Gynecol 1993;168:572–576.
- Herbst MA, Mercer BM, Beazley D, Meyer N, Carr T. Relationship of prenatal care and perinatal morbidity in low-birth-weight infants. Am J Obstet Gynecol 2003;189:930–933.